drugset / Trial / NCT04513431
A Clinical Research of CAR T Cells Targeting CEA Positive Colorectal Cancer (CRC)
NaSingle-groupOpen-labelPrevention
Summary
The main purpose of this research is to verify the safety of CEA targeted chimeric antigen receptor T cells and to determine the proper dosage of CAR T cells infused.
Timeline
- Start
- 2020-08-30
- Primary completion
- 2021-03-30
- Completion
- 2023-08-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Anti-CEA-CAR T | Cell therapy | — | — |